Clinical characteristics
For 43 patients, including 28 cases in active group and 15 cases in stable group ,we outlined the 172 ROI of lesions in bilateral sacroiliac joints, including 80 lesions in the iliac side, 32 lesions in the sacral side in the active group and 36 lesions in the iliac side, 32 lesions in the sacral side in the stable group. All ROI features were randomly assigned to the training cohort (n=116) and the validation cohort (n=56) in the ratio of 7:3. Table 1 showed the clinical characteristics of patients in the two cohorts. There were no significant differences in age and gender between the two cohorts. ESR values were no significant differences in the validation cohort. However, the values of HLA-B27, ESR, CRP, ASDAS-ESR、ASDAS-CRP、SPARCC scores and ADC were statistically significant in the two cohorts.
Table 1 Clinical features of patients in the training and validation cohorts
Feature
|
Cohort
|
Active group
(n=80/32)
|
Stable group
(n=36/24)
|
Z(χ2)
|
P
|
Age
(year)
|
Training
|
29.00±13.25
|
27.00±9.00
|
-0.144
|
0.886
|
Validation
|
24.5±20.75
|
31.00±4.00
|
-2.265
|
0.240
|
Gender
(Male /Female)
|
Training
|
56/24
|
24/12
|
1.29a
|
0.720
|
Validation
|
28/4
|
16/8
|
3.535a
|
0.060
|
HLA-B27
(+/-)
|
Training
|
72/8
|
36/0
|
3.867a
|
0.046
|
Validation
|
32/0
|
20/4
|
5.744a
|
0.017
|
ESR
(mm/h)
|
Training
|
22.5±15.5
|
9.00±9.00
|
-5.115
|
0.000
|
Validation
|
19.00±19.50
|
16.00±7.00
|
-1.599
|
0.110
|
CRP
(mg/L)
|
Training
|
12.05±16.96
|
2.12±1.11
|
-7.166
|
0.000
|
Validation
|
12.77±18.38
|
3.5±2.36
|
-5.842
|
0.000
|
ASDAS-ESR
|
Training
|
2.87±1.28
|
1.64±0.63
|
-6.019
|
0.000
|
Validation
|
2.46±1.32
|
1.82±0.33
|
-5.576
|
0.000
|
ASDAS-CRP
|
Training
|
3.48±1.80
|
1.51±0.54
|
-7.070
|
0.000
|
Validation
|
2.85±1.49
|
1.37±1.11
|
-6.107
|
0.000
|
BASDA
(score)
|
Training
|
5.79±1.28
|
4.70±0.70
|
-5.788
|
0.000
|
Validation
|
5.55±0.73
|
5.00±0.80
|
-5.068
|
0.000
|
SPARCC
(score)
|
Training
|
37.5±20.00
|
17.00±3.00
|
-7.077
|
0.000
|
Validation
|
33.00±23.25
|
15.5±8.00
|
-4.918
|
0.000
|
ADC(×10-4mm2/s)
|
Training
|
6.43±4.00
|
5.12±1.93
|
-4.810
|
0.000
|
Validation
|
7.02±4.27
|
4.61±1.41
|
-4.470
|
0.000
|
The Mann-Whitney U test and chi-squared test for comparison of all values. HLA-B27: Human Leukocyte Antigen-B27;ESR: Erythrocyte Sedimentiation Rate; CRP: C-reactive Protein; ASDAS: Ankylosing Spondylitis Disease Activity Score; BASDAI: Bath Ankylosing Spondylitis Disease Activity Score; SPARCC:Spondyloarthritis Research Consortium of Canada;ADC: Apparent Diffusion Coefficient;
Radscore building and diagnostic validation based on STIR
Eight texture features of 895 radiomics features subsets were selected to establish the Rad-score with the Mann Whitney U test, mRMR and LASSO regression model (Fig3).
Radscore=0.823*STIR_wavelet_HHH_gldm_SmallDependenceLowGrayLevel+0.456*STIR_original_gldm_Large Dependence High Gray Level+0.396*STIR
_wavelet_LHH_glrlm_Gray Level Non Uniformity+0.321*STIR_wavelet_LLH
_glcm_Correlation+0.067*STIR_wavelet_LLL_glszm_Large Area High Gray Level+ -0.089*STIR_wavelet_HHH_ngtdm_Strength+-0.279*STIR_wavelet_LLH_glcm_ Maximal Correlation Coefficient+-0.382*STIR_wavelet_ HHH_ glcm_ Cluster Shade
ROC curve analysis of Radscore, SPARCC score and ADC value
In the training cohort, the optimal cut-off values (AUC, AC,SEN,SPE,PPV,NPV) for differentiating early as sacroiliac joint bone marrow edema between active group and stable group were Radscore=51.46(0.81,76.72%,81.25%,66.67%,84.42%,61.54%), SPARCC =20scores(0.91,89.66%,90.00%,88.89%,94.97%,80.00%),
ADC=6.71×10-4mm2/s(0.78,2.93%,48.75%,94.44%,95.12%,45.33%).
In the validation cohort, the optimal cut-off values (AUC,AC,SEN,SPE,PPV,NPV) for differentiating early as sacroiliac joint bone marrow edema between active and stable group were Radscore=51.46(0.87,82.14%,90.65%,70.83%,80.56%,85.00%),
SPARCC=20score(0.89,78.57%,87.50%,66.67%,77.78%,80.00%),
ADC=6.71×10-4mm2/s(0.85,71.42%,53.13%,95.83%,94.44%,60.53%).
In the training and validation cohorts, there were no significant differences in AUC between Radscore and SPARCC score, ADC value (P>0.05). There were significant differences in AUC in the training cohort between SPARCC score and ADC value (P<0.05), without statistical significance in the validation cohort (P>0.05). (Table 2,3, Fig 4)
Table 2 Diagnostic efficiency of different models in the training and validation cohorts
Model
|
cohort
|
TV
|
AUC
|
AC
(%)
|
SEN
(%)
|
SPE
(%)
|
PPV
(%)
|
NPV
(%)
|
Radscore
|
training
|
51.46
|
0.81
|
76.72
|
81.25
|
66.67
|
84.42
|
61.54
|
validation
|
51.46
|
0.87
|
82.14
|
90.63
|
70.83
|
80.56
|
85.00
|
SPARCC
|
training
|
20.00
|
0.91
|
89.66
|
90.00
|
88.89
|
94.74
|
80.00
|
validation
|
20.00
|
0.89
|
78.57
|
87.50
|
66.67
|
77.78
|
80.00
|
ADC
|
training
|
6.71
|
0.78
|
62.93
|
48.75
|
94.4Accuracy4
|
95.12
|
45.33
|
validation
|
6.71
|
0.85V5
|
71.42
|
53.13
|
95.83
|
94.44
|
60.53
|
The effectiveness of three methods were evaluated by ROC curve. TV: Threshold Value, AUC: Area Under Curve, AC: Accuracy; SEN: Sensitivity,SPE: Specificity, PPV: Positive Predictive Value, NPV: Negative Predictive Value
Table 3 ROC curve comparisons among different models (Delong's test)
Model
|
Training cohort
|
Validation cohort
|
Z P
|
Z P
|
Radscore-SPARCC
|
1.867
|
0.062
|
0.250
|
0.802
|
Radscore-ADC
|
0.499
|
0.618
|
0.311
|
0.756
|
SPARCC-ADC
|
3.591
|
0.000
|
0.770
|
0.441
|
ROC curves were compared among different models by Delong's test ,which were not statistically significant(p>0.05).
Correlations of between Radscore,MRI and clinical activity indexes
There were low correlations between Radscore values and SPARCC scores, ADC values, and the correlation coefficients were both 0.29 (P<0.05).
There were all low correlation between Radscore values and the values of the ESR, CRP, BASDAI, ASDAS-ESR, ASDAS-CRP, and the correlation coefficients were 0.28, 0.21, 0.37, 0.28 and 0.36, respectively (P<0.05). (Table 4)
Table4 Correlations between Radscore and clinical indicators (Spearman's rho)
Radscore
|
BASDAI
|
ESR
|
CRP
|
ASDAS
-ESR
|
ASDAS-CRP
|
SPARCC
|
ADC
|
r
|
0.28
|
0.21
|
0.37
|
0.28
|
0.36
|
0.29
|
0.29
|
P
|
0.000
|
0.005
|
4e-07
|
0.000
|
1.1e-06
|
0.000
|
0.000
|
The correlations of all values were analysed by the Spearman correlation test. Radscore :Radiomic Score; BASDAI: Bath Ankylosing Spondylitis Disease Activity Score;ESR: Erythrocyte Sedimentiation Rate; CRP:C-reactive Protein; ASDAS: Ankylosing Spondylitis Disease Activity Score; SPARCC:Spondyloarthritis Research Consortium of Canada;ADC: Apparent Diffusion Coefficient